✦ LIBER ✦

Clinical studies of LF 1695: Phase I in healthy volonteers and double blind randomized phase II study in cured Hodgkin's disease

✍ Scribed by J.M. Lang; C. Grion; A. Alesksijevic; Y. Mainguy; J.L. Kienzler; F. Oberling; M. Pascal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, par

✍ del Ser, Teodoro; Lovestone, Simon; Boada-Rovira, Mercè; Dubois, Bruno; Hüll, Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Safety and pharmacokinetics of NXN-188 a

✍ David Vaughan; Joanne Speed; Robert Medve; John S. Andrews 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Efficacy and tolerability of oral budeso

✍ Suzuki, Yasuo; Motoya, Satoshi; Takazoe, Masakazu; Kosaka, Tadashi; Date, Masata 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 614 KB

Treatment of refractory Hodgkin's diseas

✍ Wolfgang Hiddemann; Norbert Schmitz; Michael Pfreundschuh; Karl-Heinz Pflüger; J 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

Disappointing results and low tolerabili

✍ V Schleyer; S Radakovic-Fijan; S Karrer; T Zwingers; A Tanew; M Landthaler; RM S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Two single-center, double-blind, randomi

✍ Tim Mant; Stipo Jurcevic; Cameron Szakacs; Luthando Adams; John Boland; Lawrence 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 193 KB